News Release

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation

和其瑞医药单克隆抗体HMI-115获得CDE突破性疗法认定

致力于源头创新的和其瑞医药完成近2亿元人民币B+轮融资

Positive Outcome from a Phase Ib Study in Australia Treating Patients with Androgenic Alopecia

和其瑞医药宣布子宫内膜异位症全球临床二期试验中国首例患者开始给药

和其瑞医药任命陈曦为首席执行官